216 - Using Genetic Engineering to Improve the Bispecific Antibody Platform for MDS Therapy

Autor: Vallera, D.A., Felices, M., Sarhan, D., Brandt, L., Guldevall, K., Warlick, E.D., Cooley, S., Weisdorf, D.J., Onfelt, B., Miller, J.S.
Zdroj: In Leukemia Research April 2017 55 Supplement 1:S126-S126
Databáze: ScienceDirect